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Abstract
Over the past decade, zebrafish (Danio rerio) have emerged as an attractive model for in vivo drug discovery. In this study,
we explore the suitability of zebrafish larvae to rapidly evaluate the anti-inflammatory activity of natural products (NPs) and
medicinal plants used in traditional medicine for the treatment of inflammatory disorders. First, we optimized a zebrafish
assay for leukocyte migration. Inflammation was induced in four days post-fertilization (dpf) zebrafish larvae by tail
transection and co-incubation with bacterial lipopolysaccharides (LPS), resulting in a robust recruitment of leukocytes to the
zone of injury. Migrating zebrafish leukocytes were detected in situ by myeloperoxidase (MPO) staining, and anti-
inflammatory activity was semi-quantitatively scored using a standardized scale of relative leukocyte migration (RLM).
Pharmacological validation of this optimized assay was performed with a panel of anti-inflammatory drugs, demonstrating a
concentration-responsive inhibition of leukocyte migration for both steroidal and non-steroidal anti-inflammatory drugs
(SAIDs and NSAIDs). Subsequently, we evaluated the bioactivity of structurally diverse NPs with well-documented anti-
inflammatory properties. Finally, we further used this zebrafish-based assay to quantify the anti-inflammatory activity in the
aqueous and methanolic extracts of several medicinal plants. Our results indicate the suitability of this LPS-enhanced
leukocyte migration assay in zebrafish larvae as a front-line screening platform in NP discovery, including for the bioassay-
guided isolation of anti-inflammatory secondary metabolites from complex NP extracts.
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Introduction
Beginning with Hippocrates’ prescription of willow bark extract
for the relief of calor, dolor, tumor and rubor – the four cardinal signs
of inflammation – the search for novel, more efficient, and safer
anti-inflammatories remains an ongoing challenge in drug
discovery. Over time, even with the clear success of aspirin and
other non-steroidal anti-inflammatory drugs (NSAIDs), the classic
gastrointestinal and cardiovascular side effects remain a major
drawback from these therapies [1–3]. Because of the large number
of bioactive, structurally diverse secondary metabolites found in
nature, small molecules from natural sources represent an
attractive alternative for anti-inflammatory drug discovery [4].
This benefit, in combination with the rise in popularity of
zebrafish (Danio rerio – Cyprinidae) as an in vivo model to study
inflammation becomes an excellent strategy for the identification
of novel compounds.
Zebrafish have become a good model organism to study
hematopoiesis, which during embryonic development is charac-
terized by primitive erythro- and myelopoiesis occurring in the
intermediate cell mass and in the anterior lateral mesoderm
(ALM), respectively [5]. During somite stages (as early as 11 hours
post-fertilization, or hpf), zebrafish embryos express a myeloid-
specific transcription factor (pu.1), which directs the production
and maturation of granulocytes and macrophages in the ALM.
Later in development, from 26 hpf onwards, primitive macro-
phages actively migrate to engulf apoptotic cells. Subsequently a
transient wave of myelopoiesis shifts to the caudal region of the
embryo, which is followed by definitive myelopoiesis in the kidney
at 3 days post-fertilization (dpf) [5]. Essential information about
myeloid cells and their efficient participation in defending an
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injured host has also been revealed by studying inflammatory-
induced migration and resolution in zebrafish [6–10].
Similar to mammals, zebrafish have three granulocyte lineages
(heterophils, eosinophils, and basophils/mast cells), which constitute a
potent innate immune system as demonstrated by robust
migration to a site of injury or inflammation [11–13]. Equivalent
to human neutrophils, heterophils are actively implicated in acute
inflammation and express myeloperoxidase (MPO), a granulocyte-
specific marker. Also MPO-positive, eosinophils and basophils have a
functional role that is still less clear [5,12,14]. Moreover, migrating
immature macrophages have been recognized at 14–16 hpf in the
rostral region and at 22–24 hpf across the yolk sac. Mature
macrophages circulate throughout the embryo and at 48 hpf they
have been shown to migrate to sites infected with bacteria
[5,12,13,15,16].
Additionally, key advantages of zebrafish include their high
fecundity and the small size, rapid ex utero development, and
optical transparency of embryos and larvae, with which most
experiments are easily performed [5,17]. Also, only small amounts
of compounds, which are simply added to the surrounding
medium and absorbed through either gastrointestinal tract or
across their skin, are required for the rapid assessment of
pharmacological activity in vivo – a unique feature among
vertebrate animal models [18,19].
Based on the principle of generating a mechanical injury to
attract leukocytes to damaged zones, zebrafish embryos and larvae
have proven to be suitable for the investigation of the kinetics of
inflammation in vivo [7,8,12,20]. Transgenic zebrafish strains
expressing fluorescent proteins in leukocytes have allowed not
only direct in vivo visualization of the inflammatory response
[6,8,10] but also evaluation of the pharmacological activity of anti-
inflammatory candidates in high-throughput screens for the search
of new immunomodulatory lead compounds [21]. These trans-
genic reporter lines clearly present important advantages over
non-transgenic zebrafish assays for the assessment of anti-
inflammatory activity. However, their requirement for advanced
imaging equipment and software may hinder their more wide-
spread application, especially in laboratories with limited financial
resources. For these reasons, and considering that existing
zebrafish inflammation assays based on mechanical injury have
not been thoroughly evaluated to date using known anti-
inflammatory drugs, we considered the improvement and evalu-
ation of a histologically-based tail injury model in zebrafish larvae
as an attractive strategy to establish a cost-effective yet robust
front-line screening platform for anti-inflammatory natural prod-
uct discovery.
In order to establish an in vivo bioassay suitable for the screening
and bio-guided analysis of small molecules with potential anti-
inflammatory properties, we first sought to optimize an assay for
acute inflammation in zebrafish larvae at 4 dpf. This method is
based on the rationale that a robust, dual activation of the innate
immune response triggered by mechanical and biological assaults
– complete tail transection and co-incubation with lipopolysac-
charides (LPS), respectively – would be sufficient to rapidly
provide accurate initial information on the possible anti-inflam-
matory activity of compounds in question, which can be further
studied as potential drug candidates.
We next pharmacologically validated this acute inflammation
assay using a panel of anti-inflammatory drugs – including both
steroidal and non-steroidal anti-inflammatory drugs (SAIDs and
NSAIDs). Finally, we used this assay for the analysis of natural
products (NPs) with well-documented anti-inflammatory activity,
and to screen plant extracts (PEs) for the evaluation of their anti-
inflammatory effects. The data generated with these different sets
of experiments suggest that the zebrafish-based acute leukocyte
migration assay could be useful as a front-line screening tool to
identify novel anti-inflammatory small molecules. Moreover, this
assay is particularly amenable to carry out the bioassay-guided
isolation of anti-inflammatory secondary metabolites present in
crude natural product extracts, as recently described in a related
study [22].
Materials and Methods
Ethics Statement
All animal procedures were performed in accordance with
Belgian and European laws, guidelines and policies for animal
experimentation, housing and care (Belgian Royal Decree of 6
April 2010 and European Directive 2010/63/EU on the
protection of animals used for scientific purposes of 20 October
2010). This project was approved by the institutional Ethical
Committee for Animal Experimentation of the University of
Leuven (approval number P101/2010).
Animals
Adult zebrafish and embryos were raised and maintained in our
facility according to standard protocols [23]. The zebrafish strains
used in this study were: fli-1:eGFP (Ekwill background) and nacre
(nacw2, AB background). Embryos were obtained by natural
spawning and after collection and sorting, fertilized embryos were
reared in 0.3 X Danieau’s medium (17.4 mM NaCl, 0.21 mM
KCl, 0.12 mM MgSO4, 0.18 mM Ca(NO3)2, 1.5 mM HEPES
pH 7.6 and 0.03 M methylene blue) at 28uC (60.5uC). One day
after fertilization fli-1:eGFP larvae were exposed to 0.2 mM 1-
phenyl-2-thiourea (PTU; Sigma-Aldrich) to suppress melanization,
while no exposure was needed for the nacre larvae. Medium
exchange was done during the next days to ensure the viability of
embryos/larvae for the assays. Four days post-fertilization (4 dpf)
zebrafish larvae subjected to tail cut were first anesthetized by
immersion in 0.3 X Danieau’s medium containing 70 mg/ml
tricaine (ethyl 3-aminobenzoate, Sigma-Aldrich).
Solutions
Lipopolysaccharides from Salmonella typhosa ATCC 10749
(10 mg/ml, LPS, Sigma-Aldrich) were reconstituted in deionized
water (Milli-QH), aliquotted in small vials and kept at 220uC until
needed for the assay to stimulate leukocyte migration in larvae.
Stocks (10 mM) of the SAIDs and NSAIDs dexamethasone
(Sigma-Aldrich), diclofenac (VoltarenH IM/IV 75 mg/3 ml,
Novartis), indomethacin (IndocidH IV 1 mg, Ovation), piroxicam
(Piroxicam-ratiopharm 20 IM 20 mg, Rathipharm), prednisolone
(Sigma-Aldrich) and non-anti-inflammatory drugs (non-AIDs)
amantadine hydrochloride (Sigma-Aldrich), doxepin hydrochlo-
ride (Sigma-Aldrich) and melamine (Acros Organics) were
prepared either in 100% dimethyl sulphoxide (DMSO) or
deionized water, depending on compound solubility. Stocks
(50 mM) of the NPs apigenin, (2)-a-bisabolol, caffeic acid,
harpagoside, luteolin, naringenin and quercetin (Sigma-Aldrich)
were prepared in 100% DMSO and testing concentrations were
prepared on 0.3 X Danieau’s medium maintaining maximum 1%
DMSO.
Plant Extracts
To prepare the extracts, plants used in our study were: Arnica
montana L. (Asteraceae), Calendula officinalis L. (Asteraceae),
Chamaemelum nobile L. (Asteraceae), Harpagophytum procumbens DC.
ex Meisn. (Pedaliaceae), Matricaria recutita L. (Asteraceae), Capraria
Leukocyte Migration Assay in Zebrafish
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biflora L. (Scrophulariaceae), Syzygium montanum (Myrtaceae), and
Schefflera chimbuensis (Araliaceae).
Plant material. Dry material of Arnica montana (flowers),
Calendula officinalis (petals), Chamaemelum nobile (flowers), Harpago-
phytum procumbens (roots) were purchased from Pharmaflore S.A.
(Belgium). Aerial parts of Capraria biflora were collected in its
natural habitat in the Botanical Garden at the Central University
of Las Villas, Santa Clara (Cuba) and a voucher specimen (No.
08132) was deposited in the herbarium of the Botanical Garden.
Syzygium montanum, and Schefflera chimbuensis are part of the
Strathclyde Natural Products Library (SNPL) and were available
for the study through collaboration with the Strathclyde Institute
for Drug Research (SIDR) at the University of Glasgow and the
Scottish Universities Life Science Alliance (SULSA).
Preparation of the extracts. Powdered dry material (each
,30 g) of Arnica montana and Calendula officinalis were extracted with
methanol (1/10 ratio) by maceration at room temperature (x 3).
Powdered dry material of Chamaemelum nobile, Capraria biflora, and
Harpagophytum procumbens (each ,30 g) were extracted with distilled
water (1/10 ratio) for one hour at 100uC (x 3). Each extract was
evaporated to dryness in vacuum not exceeding 40uC, kept at 4uC,
and protected from light until use. The essential oil of Matricaria
recutita was purchased from Sja˚nkara (Belgium) with lot No.
1176.813. Dry methanolic extracts of Syzygium montanum and
Schefflera chimbuensis were provided by SNPL.
Toxicological Evaluation
For the toxicological analysis, ten 4 dpf zebrafish larvae were
used per well in 24-well culture plates. Incubation of each set of
larvae at 28uC (60.5) was done with SAIDs, NSAIDs and non-
AIDs at concentrations ranging from 0.1 mM to 500 mM, with NPs
at concentrations ranging from 1 mM to 500 mM, and with PEs at
concentrations ranging from 1 ug/ml to 1 mg/ml. Controls
containing only vehicle (1% DMSO) and untreated larvae were
processed in parallel. Examination of each set of larvae was done
under light microscopy (Carl Zeiss Stemi 2000C) each hour during
a period of 8 h, and a final evaluation at 24 h post-incubation. At
8 h post-incubation, signs of toxicity, e.g. pericardial oedema,
cardiovascular defects (arrhythmia or decreased circulation),
balance defects (loss of normal posture), locomotor defects
(decreased touch response), and ultimately death were scored for
every drug, NP, and PE to further establish their maximum
tolerated concentration (MTC). The MTC was defined as the
concentration at which not more than 2 out of 10 larvae exhibited
any of the signs of toxicity after 8 h post-incubation. In this
context, only non-toxic concentrations (below the MTC) were
considered for further leukocyte migration analysis. All the
toxicological assays were performed in duplicate using a different
batch of zebrafish larvae for each set of experiments.
Leukocyte Migration Assay
LPS-Enhanced leukocyte migration assay. The lipopoly-
saccharide- (LPS2)enhanced leukocyte migration assay was
carried out by triplicate for each sample in 4 dpf zebrafish larvae.
The total incubation period of the assay was eight hours. Initially,
a pre-incubation step (i.e. prior to tail transection) of one hour at
28uC (60.5uC) was carried out in 24-well culture plates. Ten
larvae per well were incubated in 1 ml of testing mix, consisting of
a specific concentration of each sample and the amount of 0.3 X
Danieau’s medium necessary to complete 1 ml. Immediately after
pre-incubation, complete tail transection in each larva was
performed. Zebrafish larvae were first anesthetized by immersion
in 0.3 X Danieau’s medium containing 70 mg/ml tricaine (ethyl 3-
aminobenzoate, Sigma-Aldrich) and then tail transection near the
tip was performed with a sterile scalpel under light microscopy
(Carl Zeiss Stemi 2000C). Larvae were then placed in fresh 0.3 X
Danieau’s medium without anesthetic for a few minutes until the
final incubation period. For the last step, a new testing mix was
prepared including 10 mg/ml lipopolysaccharides from Salmonella
typhosa ATCC 10749 (LPS, Sigma-Aldrich Chemical) to enhance
leukocyte migration to the injured zone. The final incubation step
(i.e. subsequent to tail transection) of the injured larvae in contact
with the pro-inflammatory agent and with the specific concentra-
tion of each SAID, NSAID, non-AID, NP, and PE at 28uC
(60.5uC) was done for 7 h. Within this period, sporadic
evaluations of the larvae were done to examine their viability
during the time of the assay. Larvae that completed the incubation
time were fixed overnight in 4% formaldehyde (Sigma-Aldrich) at
4uC. Controls containing only the vehicle (1% DMSO) were
processed in parallel.
Cytochemical myeloperoxidase staining. Fixed larvae
were gently washed twice with 1 X PBST (PBS-1X phosphate
buffered saline, Gibco +0.1% Tween 20) for 5–10 min and then
incubated at room temperature in 1 ml of freshly prepared
LeucognostH Pox (Merck) staining solution, made according the
directions of the provider. Observation of stained black-brown
cells (leukocytes) in the larvae was possible within 15 min of
incubation. Evaluation of the migrating leukocytes, particularly
surrounding the injured region, in each larva was done under light
microscopy (Carl Zeiss Stemi 2000C) and scoring was done using a
migration scale established to semi-quantify the amount of
migrating leukocytes on one side of each larva.
Relative leukocyte migration calculation. The average of
the value achieved for each of the ten larvae tested in triplicate for
one sample is expressed as relative leukocyte migration (RLM)
according to the formula: RLM = leukocyte migration of the
larva/average leukocyte migration of the negative control. The
average of the calculated RLM for each sample is plotted against
the control (1% DMSO) and for the interpretation of the results,
RLM #0.5 is considered as cutoff point for a significant anti-
inflammatory activity.
Imaging
Zebrafish larvae were screened for leukocyte migration using a
Stemi 2000C stereo microscope (2.0 X) from Carl Zeiss.
Micrographs of the stained tails of zebrafish larvae were taken
on a MZ10F stereo microscope (1.0 X) from Leica equipped with
a DFC310 FX digital camera using Leica Application Suite
version 3.6.0 (Build: 488) and processed with Microsoft Office
Picture Manager and Adobe Photoshop software.
Statistical Analysis
All leukocyte migration experiments were performed in side-by-
side triplicates, using ten larvae for each condition. Statistical
analysis (GraphPad Prism 5 software) was performed using one-
way analysis of variance (ANOVA) followed by Dunnetts’s test for
multiple comparisons. Unpaired t-test with Welch’s correction was
used for single comparisons of each group with the control 1%
DMSO+LPS to determine statistical significance. The criterion for
statistical significance was p,0.05 (***p,0.001, **0.001,p,0.01,
*0.01,p,0.05). Error bars on all graphs represent the standard
error of the mean (SEM).
Results
in vivo Toxicological Evaluation
Toxicological assessment of all the samples analyzed in our
study was done prior to the evaluation of their anti-inflammatory
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properties. The maximum tolerated concentrations (MTCs) were
determined at 8 h post-treatment according to toxicological
parameters including pericardial oedema, cardiovascular defects
(arrhythmia or decreased circulation), balance defects (loss of
normal posture), locomotor defects (decreased touch response),
and death. Toxicity was elicited for most of the tested drugs at a
concentration higher than 200 mM with the exception of
piroxicam (MTC 100 mM), diclofenac (MTC 10 mM), and
doxepin (MTC 100 mM). In the case of the NPs, 500 mM was
the MTC for apigenin, luteolin, quercetin and caffeic acid;
300 mM for harpagoside; and 30 mM for naringenin and (2)-a-
bisabolol. Maximum tolerated concentrations for PEs were
variable. Low toxicity was exhibited by the aqueous extracts of
Capraria. biflora (MTC 1 mg/ml), Chamaemelum nobile (MTC
700 mg/ml) and Harpagophytum procumbens (MTC 500 mg/ml),
whereas the methanolic extract of Schefflera chimbuensis induced
toxicity at concentrations higher than 100 mg/ml. Finally, the
methanolic extracts of Arnica montana, Calendula officinalis and
Syzigium montanum exhibited a common MTC of 3 mg/ml, and the
essential oil of Matricaria recutita a MTC of 10 mg/ml. Vehicle-
treated (1% DMSO) and untreated larvae were processed in
parallel to minimize experimental variability in this toxicological
evaluation.
LPS-Enhanced Leukocyte Migration towards Tail Injury
To induce the recruitment of leukocytes to a site of injury, we
performed a transection of the tail in zebrafish larvae following
previously described guidelines [12]. A series of initial experiments
was conducted using normally pigmented (Ekwill strain) zebrafish
larvae – adequately treated with 1-phenyl-2-thiourea (PTU) to
inhibit melanization [24]. This was intended to establish
experimental conditions such as 1) appropriate developmental
stage of zebrafish for the assay, 2) precise location of the tail
transection, and 3) hours post-injury required to achieve a robust
leukocyte migration response prior to detection of MPO-positive
cells. Next, we sought to avoid interference with the cytochemical
staining for MPO by any remaining melanocytes not inhibited by
the addition of PTU, and therefore used the nacre strain [25],
which has strongly reduced numbers of melanocytes in most
tissues.
Based on these preliminary experiments, we determined that we
could obtain the most consistent and robust leukocyte migratory
response if zebrafish larvae at 4 dpf were subjected to a complete
tail transection made in a target region comprising 0.5 mm
(60.2 mm, tolerated range) from the tip of the tail of each larva
(Figure 1A and 1B). Additionally, we took advantage of the strong
immune-stimulating properties elicited by bacterial LPS in order
to promote an even greater migratory response in the larvae
(Figure 1C and 1D). By co-incubation with LPS we observed
reproducible and robust congregations of leukocytes, which
clustered mainly in the affected region in the tails (Figure 1E
and 1F).
Semi-Quantification of Migrating Leukocytes
To determine the extent of leukocyte migration generated after
exposing 4 dpf zebrafish larvae to mechanical and biological
stimuli – namely tail transection and LPS exposure – we used a
commercially available whole-mount cytochemical staining meth-
od (LeucognostH Pox, Merck) to detect MPO activity in situ. To
minimize the number of handling steps post-staining, this method
was chosen over the alternative myeloperoxidase stain Sudan
Black B [26,27], which also stains phospholipids, neural fats and
sterols. In our experiments, we visualized migrating leukocytes in
4 dpf larvae at 8 h post-injury. Microscopic evaluations of MPO-
stained larvae allowed us to score the degree of leukocyte
migration at the trauma site according to a comparative scale
that we established particularly for this purpose (Figure 2).
Myeloperoxidase-positive cells, appearing as black-brown dots,
were counted in a segment at the edge of the tail on one side of
every larva (Figure 2). The number of leukocytes was then graded
according to the comparative scale and subsequently converted
into a relative value expressed as the relative leukocyte migration
(RLM) activity for the total number or larvae for one sample. In
this assay, we considered relative leukocyte migration values #0.5
to represent significant anti-inflammatory activity.
Effect of Anti-Inflammatory Drugs and Non-Anti-
Inflammatory Compounds in the Migration of Zebrafish
Leukocytes
We conducted validation experiments using a panel of SAIDs
and NSAIDs and randomly selected control compounds with no
anti-inflammatory activity. As a proof of principle, the anti-
inflammatory effect displayed by commercially available NSAIDs
(diclofenac, indomethacin and piroxicam) and SAIDs (dexameth-
asone and prednisolone) exhibited statistically significant values at
diverse concentrations, ranging from 0.1 mM to 200 mM
(Figure 3A–E). In the LPS-enhanced leukocyte migration assay,
diclofenac, indomethacin and piroxicam showed RLM values of
0.13, 0.09 and 0.03, respectively, when tested at its MTC 10, 200
and 100 mM, respectively. In contrast, the same NSAIDs
evaluated at a lower concentration (0.1 mM) displayed RLM of
0.69 for diclofenac, 0.72 for indomethacin and 0.85 for piroxicam,
corresponding to a low inhibition of migrating leukocytes. For the
SAIDs dexamethasone and prednisolone, RLMs of 0.06 and 0.07
were achieved respectively at 200 mM whereas RLM values of
0.81 and 0.66 at 0.1 mM indicated a poor effect on the inhibition
of leukocyte migration (Figure 3D–E).
As expected, the non-anti-inflammatory compounds tested in
our assay – amantadine, doxepin and melamine – did not have a
significant effect on the inhibition of leukocyte migration since all
the tested concentrations in our experiments gave RLM values
much higher than the cutoff (RLM #0.5). Thus, amantadine and
melamine (both evaluated at their MTC 200 mM) and doxepin
(MTC 30 mM) showed RLM values of 0.82, 0.85 and 0.71,
respectively (Figure 3F–H).
Consequently, these results showed that the zebrafish-based
leukocyte migration method was able to detect an expected anti-
inflammatory activity revealed by the concentration-dependent
decrease of leukocyte migration towards the injured tail region in
the larvae.
Evaluation of the Anti-Inflammatory Activity of Natural
Products in the LPS-Enhanced Leukocyte Migration Assay
After pharmacologically validating the LPS-enhanced leukocyte
migration assay by demonstrating a dose-response inhibition of
leukocyte migration in zebrafish larvae exposed to SAIDs and
NSAIDs, we next used the assay to evaluate the anti-inflammatory
effect of NPs. For this purpose we used small molecules derived
from plant species and with well-documented anti-inflammatory
activity in other models (in vivo and in vitro), including four
flavonoids (apigenin, naringenin, luteolin, and quercetin), one
sesquiterpenoid ((2)-a-bisabolol)), one iridoid (harpagoside), and
one phenolic compound (caffeic acid).
All flavonoids – apigenin, naringenin, luteolin, and quercetin –
showed moderate but significant anti-inflammatory activity up to
their MTCs. Particularly apigenin and quercetin tested at their
common MTC (500 mM) resulted in RLM values of 0.35 and
Leukocyte Migration Assay in Zebrafish
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e75404
Figure 1. LPS-enhanced leukocyte migration assay in 4 dpf zebrafish larvae. All larvae (nacre) are four days post-fertilization (4 dpf), with
anterior to the left, scale bar = 10 mm. A, tail of alive larva without tail cut; B, tail of alive larva with tail cut; C–D, whole-mount MPO staining in uncut
tails of zebrafish larvae; C, without lipopolysaccharides (2LPS) and D, with lipopolysaccharides (+LPS); E–F, whole-mount MPO staining in cut tails of
zebrafish larvae; E, without the inclusion of LPS; F, with the inclusion of LPS. Dark-spots (marked by arrows) represent the migrating leukocytes,
which are semi-quantified in the region to the right of the dashed red arc.
doi:10.1371/journal.pone.0075404.g001
Figure 2. Scoring of leukocyte migration in the transected tails of zebrafish larvae. All larvae (nacre) are four days post-fertilization (4 dpf),
with anterior to the left, scale bar = 10 mm. Dark spots (marked by arrows) represent leukocytes migrating to the injured zone in the transected tails.
Migrating leukocytes were counted in the region to the right of the dashed red arc. A, tail of an uncut larva; B, tail-cut with score 0; C, tail-cut with
score 1; D, tail-cut with score 2; E tail-cut with score 3; F, tail-cut with score 4. aExperimental values obtained for each larvae are normalized to a
relative value expressed as relative leukocyte migration (RLM); +LPS: with inclusion of lipopolysaccharides. bPercentage of anti-inflammatory activity
is obtained as (12RLM)x100.
doi:10.1371/journal.pone.0075404.g002
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0.31, respectively, corresponding to 65 and 69%, respectively,
anti-inflammatory activity. Similarly, naringenin (MTC 30 mM)
showed significant effects, with a RLM value of 0.37. In all cases,
only weak inhibition of leukocyte migration was reached with low
concentrations of the flavonoids (Table 1).
Moderate inhibition of leukocytes migration was also displayed
by the sesquiterpene (2)-a-bisabolol. Relative leukocyte migration
values achieved with high concentrations (0.50 at 10 mM and 0.48
at 30 mM) yet fulfilled our cut-off criteria for significant anti-
inflammatory activity (#0.5). More interestingly, in our LPS-
enhanced assay the iridoid harpagoside and the phenolic
compound caffeic acid inhibited the migration of leukocytes to
the injured zone in a dose-response manner (Table 1). High
concentrations of both NPs achieved RLM values of 0.12
(harpagoside) and 0.14 (caffeic acid), corresponding to significant
anti-inflammatory activity.
Screen for Anti-Inflammatory Activity in Plant Extracts
The LPS-enhanced leukocyte migration assay was next used as
an in vivo tool to screen for anti-inflammatory activity in crude
extracts of diverse NPs. Based on ethnomedicinal uses, six plant
species from different genera were selected for evaluation of their
Figure 3. Inhibition of the leukocyte migration by known anti-inflammatory drugs and non anti-inflammatory compounds. After
exposing the larvae to mechanical and biological damages, anti-inflammatory drugs and non anti-inflammatory compounds were evaluated for their
activity in the LPS-enhanced leukocyte migration assay. Migrating MPO-positive cells were counted in the tail tip and the results expressed as relative
leukocyte migration (RLM) values. Results for NSAIDs (upper panel) and SAIDs (middle panel) show a significant inhibition of leukocytes migration in a
concentration-dependent manner while non anti-inflammatory drugs (lower panel) indicate no significant effect on leukocyte migration. In each case,
values are plotted as RLM (SEM, n= 3 replicates with 10 larvae each) and a value of 0.5 was established as a cut-off for anti-inflammatory activity.
***p,0.001, **0.001,p,0.01, *0.01,p,0.05.
doi:10.1371/journal.pone.0075404.g003
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anti-inflammatory activity in our established acute inflammation
assay in zebrafish. The selection included Arnica montana, Calendula
officinalis, Chamaemelum nobile, Harpagophytum procumbens, Matricaria
recutita, and Capraria biflora. Moreover, two randomly chosen
species – Syzygium montanum and Schefflera chimbuensis, both without
previous ethnopharmacological data – were also included in the
study. However, after initial in vivo toxicological evaluation, A.
montana, C. officinalis, M. recutita, and S. montanum were left out of the
screen due to their toxicity effects.
When tested in the LPS-enhanced leukocyte migration assay,
aqueous extracts of C. nobile, H. procumbens, and C. biflora; and
methanolic extracts of S. chimbuensis showed concentration-
dependent anti-inflammatory activity. These effects were reflected
by the gradual decrease in the migration of leukocytes to the
injured tail and therefore by decline in RLM values, as depicted in
Figure 4. In addition to the (expected) anti-inflammatory activity
of C. nobile (RLM 0.48 at MTC) and H. procumbens (RLM 0.46 at
MTC), our screening results confirmed the anti-inflammatory
activity of C. biflora. At their MTC, clustering of leukocytes in the
damaged zone in the tails of the larvae was significantly reduced
and an RLM value of 0.23 was achieved. Interestingly, C. biflora is
used in traditional medicine in some countries in Latin America
for the treatment of diverse inflammatory conditions [28–30].
Furthermore, moderate anti-inflammatory activity (60% inhibition
at its MTC) was obtained with the extract of S. chimbuensis, for
which no previous reports on anti-inflammatory activity have been
described.
In general, these results demonstrate a dose-dependent anti-
inflammatory effect for all the plant extracts tested in our LPS-
enhanced assay (Figure 4). In addition, these results confirm the
amenability of the model and the ability of the assay to easily
screen and detect even mild anti-inflammatory effects in crude
extracts of diverse plant species.
Discussion
Recently, our laboratory has established zebrafish as a
biodiscovery platform to screen for novel active molecules, using
zebrafish-based assays in particular for the bioassay-guided
identification of drug-like natural products [19,22,31–33] and
synthetic compounds [34]. Within this context, main objectives of
this study were first to optimize an anti-inflammatory assay in non-
transgenic zebrafish, to validate this improved assay with a panel
of steroidal and non-steroidal anti-inflammatory drugs, and to
determine the utility of this approach to analyze the anti-
inflammatory activity of medicinal plants and their bio-active
constituents.
The recent application of several transgenic zebrafish lines to
the analysis of inflammation in zebrafish – e.g. fli-1:eGFP [6,20],
BACmpx:GFP [8], zMPO:GFP [7], lysC:DsRED2 [21], and fms/mpx
[10,35] – have enabled the live, in vivo imaging of the major cell
types involved in the inflammatory response and its resolution.
One elegant study involved the non-invasive, chemically-induced
damage to lateral line neuromast cells in 56-hpf BACmpx:GFP and
lysC:DsRED2 zebrafish larvae, showing that leukocytes localize in
clusters along the damaged sensory hair cell population in the
trunk and tail of the larvae [21]. Although there are clear
advantages of these transgenic zebrafish strains for inflammation
research, there are various considerations e.g. intellectual property
constraints – that may restrict the widespread use of these tools for
drug discovery applications. Additional limitations of this more
advanced transgenic approach include the requirement for access
to fluorescence imaging equipment and software. For many
laboratories, especially those with limited financial resources,
applications of zebrafish assays will require the use of cost-efficient
assays and protocols, wherein some limitations in screening
throughput will be acceptable to achieve this. For this reason, a
non-transgenic assay based on the dual activation of the innate
immune response combined with a whole-mount in situ cytochem-
ical staining method in zebrafish larvae may be an attractive
option for the rapid in vivo characterization of novel anti-
inflammatory compounds of natural origin.
Although it has been shown that a mechanically induced wound
triggers the rapid recruitment of leukocytes in zebrafish [8,12],
several improvements to this method were necessary to render it
suitable for screening purposes in the context of a natural product
discovery effort. For instance, activation of the myeloid linage by
transection of the larval tail [8,12] could be enhanced by exposure
to Gram-negative endotoxins. Studies have shown that complete
activation of macrophages in 30 hpf embryos is achieved by
injection of large doses of either Gram-negative (Escherichia coli) or
Gram-positive (Bacillus subtilis) live bacteria [15]. However, the
injection of bacterial suspensions into embryos is time-consuming
and requires technical expertise. In contrast, the simple immersion
of larvae in solutions of LPS induces an enhanced and consistent
inflammatory response (Figure 1E and 1F). This response is
Table 1. Anti-inflammatory activity of natural products.
Natural product Leukocyte migration
a (RLM)
Anti-inflammatory activity at
MTC
1 mM 10 mM 30 mM 100 mM 300 mM 500 mM
Apigenin 0.74 0.53* 0.54 0.37* 0.37** 0.35*** 65%
Luteolin 0.63* 0.61*** 0.55* 0.48* 0.44** 0.41** 59%
Naringenin 0.67* 0.42** 0.37** T T T 63%
Quercetin 0.65 0.55* 0.35* 0.42* 0.40 0.31* 69%
(2)-a-bisabolol 0.53* 0.50* 0.48 T T T 52%
Caffeic acid 0.80 0.71 0.59* 0.59* 0.34* 0.14** 86%
Harpagoside 0.48* 0.29* 0.30* 0.15* 0.12* T 85%
aLeukocyte migration is expressed as relative values (RLM).
***p,0.001,
**0.001,p,0.01,
*0.01,p,0.05. T: toxic concentration.
doi:10.1371/journal.pone.0075404.t001
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possibly mediated by the expression of the pro-inflammatory
cytokines tumor necrosis factor alpha (TNF-a) and interleukin
(IL)-1b, as reported by others [36–38]. Moreover, LPS-mediated
release of pro-inflammatory cytokines in zebrafish is induced by
activation of Toll-like receptors (TLR) [39,40]. At least 19 TLR
variants – particularly two homologues of the human LPS-sensing
TLR (TLR4) – and different intracellular adaptor molecules –
MyD88, MAL, TRIF, SARM – are encoded in zebrafish and are
already expressed during gastrulation, indicating a strong conser-
vation of this first-line defense mechanism [39]. Interestingly,
studies in transgenic zebrafish have revealed that MyD88 is able to
trigger TLR-mediated immunity, contributing to essential re-
sponses to wounding and bacterial infection [40].
Moreover, we were able to show that migrating leukocytes can
be readily visualized with a whole-mount in situ staining procedure
based on the detection of MPO-positive cells. For this, we used a
staining kit (LeucognostH POX, Merck) for MPO activity that uses
the substrate 4-chloro-1-naphtol (4-CN) [41], which is less
hazardous than the benzidine staining [42] used previously for
the in situ detection of zebrafish leukocytes [12]. Furthermore, as
MPO-positive cells must be scored in the tail tip, we made use of
the nacre strain to avoid the presence of melanocytes, which at
4 dpf are widely distributed in the larvae and interfere visually in
the scoring process. nacre (nacw2) mutants do not express crest-
derived melanophores throughout development, however melanin
production is normal in the retinal epithelium, suggesting that the
mutation is specific to the neural crest and does not affect the
synthesis of pigment per se [25]. Alternatively, wild-type larvae (in
which melanophores first appear at 24 hpf) can be also used in the
assay as long as they have been pre-treated with PTU to inhibit
melanogenesis [24].
One caveat of this assay is that the simple detection of MPO
activity in the tail tip cannot immediately distinguish between the
inhibition of leukocyte migration and other mechanisms associated
with the resolution of inflammation (i.e. apoptosis or reverse
migration of leukocytes). However, by timing the analysis during
the peak of the inflammatory response (7 hours post-injury), any
reduction in the number of MPO-positive cells in the tail tip is
most likely to be due to inhibition of migration.
The validation of the LPS-enhanced leukocyte migration assay
in 4 dpf zebrafish larvae was performed with a panel of known
anti-inflammatory drugs – both NSAIDs and SAIDs. As expected,
the results for each drug showed gradual and significant reduction
in the migration of leukocytes towards the site of injury (Figure 3A–
E). These data correlate well with other studies showing that anti-
inflammatory drugs act as predicted at different points in the
inflammatory response in zebrafish [9,21]. Conversely, when
compounds with no known anti-inflammatory activity were tested,
no significant influence on leukocyte migration was seen since their
Figure 4. Anti-inflammatory effect of aqueous and methanolic plan extracts. Anti-inflammatory activity of aqueous and methanolic plant
extracts was evaluated in the LPS-enhanced leukocyte migration assay. A concentration-dependent inhibitory trend was observed for Capraria biflora
(A), Chamaemelum nobile (B), Harpagophytum procumbens (C), and Schefflera chimbuensis (D). Values are plotted as relative leukocyte migration, RLM
(SEM, n= 3 replicates with 10 larvae each) and a value of 0.5 was established as a cut-off for anti-inflammatory activity. ***p,0.001, **0.001,p,0.01,
*0.01,p,0.05.
doi:10.1371/journal.pone.0075404.g004
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RLM values did not approach our established cut-off of 0.5
(Figure 3F–H).
To explore the suitability of the LPS-enhanced leukocyte
migration assay, we next used it to test the anti-inflammatory
activity of NPs, focusing initially on flavonoids, terpenes, phenolic
compounds and iridiods as common, low-molecular weight
secondary metabolites responsible for the anti-inflammatory
properties of different species in diverse plant genera (e.g.
apigenin, luteolin, quercetin, (2)-a-bisabolol in C. nobile and
harpagoside in H. procumbens) [43–46]. Consistent with what has
been reported in other models, our results showed that all tested
NPs displayed a concentration-dependent anti-inflammatory
response. (2)-a-bisabolol, apigenin, luteolin, naringenin and
quercetin all moderately inhibited leukocyte migration in the
LPS-enhanced leukocyte migration assay. Their anti-inflammatory
activity might be exerted via various mechanisms of action
including inhibition of the production of pro-inflammatory
cytokines (IL-1b, IL-6, IL-8 and TNF-a) and cyclooxygenase
(COX) and lipoxygenase (LOX) enzymes [47–50]. Similarly,
caffeic acid and harpagoside exhibited a significant anti-inflam-
matory response in our assay. Likely, these effects might be also
mediated by inhibition of the production of pro-inflammatory
cytokines and nitric oxide, as well as for the inhibition of COX
enzymes, as demonstrated in other studies [43,51–53]. A
comparative vision of the anti-inflammatory effects observed with
these NPs in the LPS-enhanced leukocyte migration assay in
zebrafish and other in vivo and in vitro models is given in Table 2.
In the context of a NP-based drug discovery approach, we also
made use of the LPS-enhanced leukocyte migration assay to
investigate the anti-inflammatory activity of plants used in
traditional medicine. Species with well-documented anti-inflam-
matory activity such as C. nobile [44,46] and H. procumbens [43,60]
were moderately active in our assay at their MTCs (Figure 4). In
contrast, crude extracts of A. montana and C. officinalis, and the
essential oil of M. recutita were highly toxic for the zebrafish larvae
and no anti-inflammatory date could be obtained. These
observations led us speculate about the limited indication for oral
administration that these samples have, which in the larvae could
not be controlled since small molecules are not only taken up by
the gills and skin, but also by the gastrointestinal tract.
A significant concentration-dependent anti-inflammatory re-
sponse was induced by C. biflora (Figure 4). These results correlate
with other studies in which the aqueous extract of the plant
showed a dose-dependent anti-inflammatory effect in in vivo
models of inflammation (carrageenan-induced paw edema in rats
and the peritonitis induced by carrageenan in mouse) [28].
Flavonoids have been suggested as responsible for the anti-
inflammatory properties of C. biflora. This hypothesis has been, in
addition, partially confirmed by our group by the identification of
apigenin and luteolin in the aqueous extract of the leaves of the
plant (data not shown).
In summary, these data support the further use of this zebrafish-
based assay to screen for anti-inflammatory plant extracts, and as
shown in a recent published work [22], to contribute to the
bioassay-guided fractionation of such extracts for the rapid
isolation and quantitative bioactivity analysis of their anti-
inflammatory constituents.
Conclusion
Numerous therapeutic agents are commercially available to
treat short and long-term inflammatory diseases. Nevertheless,
there is still need for the discovery of novel anti-inflammatory
drugs with improved potency and reduced side effects. Natural
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products will play a key role in this regard as they represent an
attractive source of chemical diversity. A significant percentage of
the worldwide population still relies on the use of phytotherapies
for the treatment of inflammatory conditions, making medicinal
plants used for these purposes an excellent source of potentially
anti-inflammatory secondary metabolites. Taking these factors
into account, in this study we report the optimization and
validation of an acute leukocyte migration method in zebrafish
larvae to rapidly assess the in vivo anti-inflammatory activity of
small molecules of natural origin. In addition to the advantages of
a zebrafish-based assay over other in vivo models, we further show
that this LPS-enhanced leukocyte migration assay is suitable for
the analysis of the anti-inflammatory properties of plant extracts
and for the identification of their bioactive constituents.
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